$ACCV

JONES GINGER M purchased $180K of ACCV

JONES GINGER M purchased 10,000 shares of Accelevation Holdings Corp. (ACCV) at $18.00 ($0.18M total) on 2026-10-01.

Original reporting
SEC EDGAR · JONES GINGER M
Published Oct 6, 2026, 1:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACCV
Neutral
medium confidence
Mentioned
$ACCV
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACCVNeutralLow
01

Why it matters

The disclosed purchase provides a fresh data point for traders monitoring insider activity, but the amount is modest.

02

Market read

New insider purchase adds a small positive signal for ACCV but is unlikely to drive significant price movement.

03

What to watch

If the company's float is very small, even a $180K buy could be more material than it appears.

Relevance 5/10Novelty 4/10Timing: filing date 2026-10-05, after market close

Background

SEC Form 4 filings disclose insider transactions; this filing reports a director's purchase of ACCV shares.

Company-level read

Ticker impact

$ACCVNeutralMedium confidence
Context

Director JONES GINGER M bought 10,000 shares of Accelevation Holdings for $180,000 in a Form 4 filing.

Expected impact

slight upward pressure as market interprets insider confidence

Evidence & confidence

The transaction size is modest relative to typical float; however, insider buying is a positive signal.

Market effects

Minimal impact on the broader sector; insider activity is company‑specific.

No discernible regional effect.

Limited to investors tracking ACCV.

Counterpoint

The purchase could be a routine portfolio rebalancing, not a strong endorsement.

Key entities

  • Accelevation Holdings Corp.

    Issuer of the shares purchased.

  • JONES GINGER M

    Director of Accelevation Holdings who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Accelevation's SkyBridge bookings strengthen Bank of America's bullish outlook

Bank of America initiated coverage of Accelevation with a 'buy' rating and $20 price target, citing strong demand for data center equipment. The bank expects adjusted EBITDA to grow at a 56% CAGR from 2026 to 2030, driven by AI infrastructure investments. Accelevation's SkyBridge platform secured $700M in bookings, and the company benefits from a domestic manufacturing footprint and skilled labor.

$ACCVHigh

JPMorgan initiates Accelevation stock with overweight rating

JPMorgan initiated coverage on Accelevation Holdings (NASDAQ:ACCV) with an overweight rating and a $20.00 price target for December 2027, implying 60% upside. The stock trades at $12.38, near its 52-week low. The company reported $726.6M revenue, 29.3% gross margin, and a 1.93 current ratio. JPMorgan cited a $1.1B backlog and modular scaling capabilities as strengths, while noting risks like hyperscaler capex timing and customer concentration.

Med

Accelevation Secures $650 Million Credit Agreement Led By Bank Of America, JPMorgan, Morgan Stanley, KeyBank And PNC

Accelevation Holdings secured a $650 million credit agreement, including a $400 million revolving facility and a $250 million Term Loan A, both maturing in 2031. The new financing reduces borrowing rates and strengthens the company's balance sheet, according to the company. Bank of America, JPMorgan, Morgan Stanley, KeyBank, and PNC were involved in the agreement.